CIK 1510989
Informed Momentum Co LLC
Institutional 13F holdings & portfolio
Holdings
268
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
1
Holdings
13F filings as of Dec 31, 2025 · Showing 201–250 of 268
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| ZUMZ | Zumiez Inc | 42K | $1M+ | SH |
| LAW | CS Disco Inc | 139K | $1M+ | SH |
| APEI | American Public Education Inc | 28K | $1M+ | SH |
| ACNB | ACNB Corp | 22K | $1M+ | SH |
| LTRX | Lantronix Inc | 180K | $1M+ | SH |
| IDN | Intellicheck Inc | 151K | $1M+ | SH |
| NRGV | Energy Vault Holdings Inc | 219K | $1M+ | SH |
| VTYX | Ventyx Biosciences Inc | 111K | $1M+ | SH |
| ASMB | Assembly Biosciences Inc | 30K | $1M+ | SH |
| AQST | Aquestive Therapeutics Inc | 155K | $1M+ | SH |
| NWPX | NWPX Infrastructure Inc | 16K | $500K+ | SH |
| ISSC | Innovative Solutions and Support Inc | 52K | $500K+ | SH |
| SND | Smart Sand Inc | 240K | $500K+ | SH |
| OPXS | Optex Systems Holdings Inc | 67K | $500K+ | SH |
| ASYS | Amtech Systems Inc | 74K | $500K+ | SH |
| TWIN | Twin Disc Inc | 53K | $500K+ | SH |
| IHRT | iHeartMedia Inc | 210K | $500K+ | SH |
| USAU | US Gold Corp | 45K | $500K+ | SH |
| CTMX | CytomX Therapeutics Inc | 204K | $500K+ | SH |
| GOSS | Gossamer Bio Inc | 278K | $500K+ | SH |
| APYX | Apyx Medical Corp | 246K | $500K+ | SH |
| HLLY | Holley Inc | 204K | $500K+ | SH |
| FTCI | FTC Solar Inc | 77K | $500K+ | SH |
| NATR | Nature's Sunshine Products Inc | 38K | $500K+ | SH |
| PESI | Perma-Fix Environmental Services Inc | 65K | $500K+ | SH |
| SENEA | Seneca Foods Corp | 7K | $500K+ | SH |
| MRAM | Everspin Technologies Inc | 87K | $500K+ | SH |
| EGAN | eGain Corp | 78K | $500K+ | SH |
| KRMD | KORU Medical Systems Inc | 137K | $500K+ | SH |
| AP | Ampco-Pittsburgh Corp | 148K | $500K+ | SH |
| RLMD | Relmada Therapeutics Inc | 163K | $500K+ | SH |
| ESQ | Esquire Financial Holdings Inc | 8K | $500K+ | SH |
| TCBX | Third Coast Bancshares Inc | 20K | $500K+ | SH |
| FOSL | Fossil Group Inc | 201K | $500K+ | SH |
| MNPR | Monopar Therapeutics Inc | 11K | $500K+ | SH |
| DSGN | Design Therapeutics Inc | 79K | $500K+ | SH |
| LCTX | Lineage Cell Therapeutics Inc | 442K | $500K+ | SH |
| DMAC | DiaMedica Therapeutics Inc | 91K | $500K+ | SH |
| IZEA | IZEA Worldwide Inc | 166K | $500K+ | SH |
| CXDO | Crexendo Inc | 111K | $500K+ | SH |
| FULC | Fulcrum Therapeutics Inc | 62K | $500K+ | SH |
| DERM | Fortress Biotech Inc | 89K | $500K+ | SH |
| CODA | Coda Octopus Group Inc | 74K | $500K+ | SH |
| TOI | Oncology Institute Inc/The | 183K | $500K+ | SH |
| ENTA | Enanta Pharmaceuticals Inc | 41K | $500K+ | SH |
| AMLX | Amylyx Pharmaceuticals Inc | 53K | $500K+ | SH |
| IMMX | Immix Biopharma Inc | 121K | $500K+ | SH |
| XERS | Xeris Biopharma Holdings Inc | 80K | $500K+ | SH |
| PPIH | Perma-Pipe International Holdings Inc | 20K | $500K+ | SH |
| KFS | Kingsway Financial Services Inc | 43K | $500K+ | SH |